Comparative effectiveness research: Relative successes

JAMA

Volumn 307, Issue 15, 2012, Pages 1643-1645

  Golub, Robert M ^a   Fontanarosa, Phil B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; PACLITAXEL;

ABDOMINAL AORTA ANEURYSM; BIOMEDICINE; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; DECISION MAKING; DESCENDING AORTA SURGERY; EDITORIAL; EFFECT SIZE; EVIDENCE BASED MEDICINE; FUNDING; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; KIDNEY CANCER; LUNG NON SMALL CELL CANCER; MEDICAL RESEARCH; METHODOLOGY; OBSERVATIONAL STUDY; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; UNITED STATES;

EID: 84859818395     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.490     Document Type: Editorial

References (17)

1. Department of Health and Human Services. Supporting Comparative Effectiveness Research. http://www.hhs.gov/recovery/reports/plans/ahrq-cer-plan. pdf. Accessed March 26, 2012.
2. Patient Protection and Affordable Care Act, Pub L No. 111-148, 124 Stat 727 (2010).
3. Agency for Healthcare Research and Quality. Effective Health Care Program. http://www.effectivehealthcare.ahrq.gov/index.cfm/what-is-comparative- effectiveness-research1. Accessed March 26, 2012.
4. Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med. 2009;151(3):203-205.
5. Golub RM, Fontanarosa PB. 2012 Theme issue on comparative effectiveness research-call for papers. JAMA. 2011;305(7):717.
6. Zhu J, Sharma DB, Gray SW, Chen AB, Weeks JC, Schrag D. Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA. 2012;307(15):1593-1601.
7. Sheets NC, Goldin GH, Meyer A-M, et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA. 2012;307(15):1611-1620.
8. Tan H-J, Norton EC, Ye Z, Hafez KS, Gore JL, Miller DC. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA. 2012;307(15):1629-1635.
9. Galvagno Jr SM, Haut ER, Zafar SN, et al. Association between helicopter vs ground emergency medical services and survival for adults with major trauma. JAMA. 2012;307(15):1602-1610.
10. Jackson RS, Chang DC, Freischlag JA. Comparison of long-term survival after open vs endovascular repair of intact abdominal aortic aneurysm among Medicare beneficiaries. JAMA. 2012;307(15):1621-1628.
11. Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA. 2012;307(15):1583-1584.
12. Kent DM, Shah ND. Risk models and patient-centered evidence: should physicians expect one right answer? JAMA. 2012;307(15):1585-1586.
13. Mullins CD, Abdulhalim AM, Lavallee DM. Continuous patient engagement in comparative effectiveness research. JAMA. 2012;307(15):1587-1588.
14. Kass N, Faden R, Tunis S. Addressing low-risk comparative effectiveness research in proposed changes to US federal regulations governing research. JAMA. 2012;307(15):1589-1590.
15. Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI). Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. JAMA. 2012;307(15):1636-1640.
16. Concato J. Is it time for medicine-based evidence? JAMA. 2012;307(15): 1641-1643.
17. Vaughan Sarrazin MS, Rosenthal GE. Finding pure and simple truths with administrative data. JAMA. 2012;307(13):1433-1435.